Colbeck Capital Management, a leading middle-market private credit firm focused on strategic lending, today announced its continued support of the Children’s Tumor Foundation (“CTF” or the “Foundation”) through sponsorship of its 2026 New York City Charity Poker Tournament. The tournament, to be held June 18 at The Prince George Ballroom, brings supporters together for the Children's Tumor Foundation and features a cocktail reception followed by Texas Hold 'Em tournament play.

Every buy-in, sponsorship, and donation advances the Foundation's work to end neurofibromatosis and schwannomatosis (collectively known as NF), a group of genetic conditions that cause tumors to form on nerves throughout the body. Support from Jason Colodne and Colbeck Capital helps drive research, expand knowledge, and advance care for individuals and families affected by NF.

Founded in 1978, the Children's Tumor Foundation has served as the drug discovery engine for NF, working to put treatments in patients' hands sooner. By uniting doctors, scientists, pharmaceutical partners, and affected families behind a single goal, CTF takes a patient-first, collaborative approach that speeds drug development and brings life-changing therapies to those living with neurofibromatosis and schwannomatosis. To learn more about the event, please click here.

About Colbeck Capital Management
Colbeck Capital Management (colbeck.com) is a leading, middle-market private credit manager focused on strategic lending. Colbeck originates senior secured loans to companies going through periods of transition, providing creative capital solutions. Colbeck sponsors its portfolio companies through consistent engagement with management teams in areas such as finance, capital markets and growth strategies, distinguishing itself from traditional lenders. Colbeck was founded in 2009 by Jason Colodne and Jason Beckman and currently manages $3+ billion of invested and committed capital. Colbeck’s principals have extensive experience investing through different market cycles at leading institutions, including Goldman Sachs and Morgan Stanley.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260618110397/en/